AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France.
INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
Sex Transm Infect. 2018 Nov;94(7):475-478. doi: 10.1136/sextrans-2017-053131. Epub 2017 Aug 23.
HIV testing is an important step towards diminishing incident infections. Rapid self-tests whose use is becoming more common in France could help increase access to testing, yet could fail to diagnose HIV during acute HIV infection (AHI). The aim of the present study was to evaluate HIV-detection sensitivity of a commonly used rapid self-test (STAT-VIEW HIV1/2), compared with another point-of-care rapid test (INSTI), among patients presenting with AHI.
Individuals tested at Saint-Antoine Hospital (Paris, France) with negative or indeterminate western blot (WB) results and detectable HIV-RNA were included. Rapid tests were performed retrospectively on stored serum. Patients with and without reactive rapid tests were compared, while probability of having a reactive test was modelled across infection duration using logistic regression.
Of the 40 patients with AHI, 23 (57.5%) had a reactive STAT-VIEW rapid test. Patients with non-reactive versus reactive tests had a significantly shorter median time since infection (p=0.01), time since onset of symptoms (p=0.009), higher proportion with Fiebig stage III versus IV (p=0.003), negative WB results (p=0.007), higher HIV-RNA levels (p=0.001) and lower CD4+ and CD8+ cell count (p=0.03, p<0.001, respectively). When examining sensitivity over the course of AHI duration, the probability of HIV detection was 75.5% at 5 weeks from HIV transmission. The INSTI provided similar results with respect to proportion of reactive tests (62.5%), determinants for non-reactive test and probability of HIV detection at 5 weeks of infection (85.0%).
Over half of AHI patients had reactive serology using the STAT-VIEW rapid self-test when performed on serum samples. Considering that detection sensitivity increased substantially over infection time, individuals should not rely on a negative result to accurately exclude HIV infection within at least 5 weeks of potential HIV exposure. Notwithstanding strong recommendations against rapid test use during AHI, some utility in detecting HIV is observed 5-12 weeks after transmission.
艾滋病毒检测是减少新发感染的重要步骤。在法国,使用越来越普遍的快速自我检测可能有助于增加检测机会,但可能无法在急性艾滋病毒感染(AHI)期间诊断出艾滋病毒。本研究的目的是评估一种常用的快速自我检测(STAT-VIEW HIV1/2)与另一种即时检测(INSTI)相比,在出现 AHI 的患者中的 HIV 检测灵敏度。
纳入在圣安东尼医院(巴黎,法国)检测出阴性或不确定的 Western blot(WB)结果和可检测到 HIV-RNA 的个体。使用存储的血清对快速检测进行回顾性检测。比较快速检测阳性和阴性的患者,同时使用逻辑回归模型在感染持续时间范围内分析快速检测阳性的概率。
40 名 AHI 患者中,有 23 名(57.5%)的 STAT-VIEW 快速检测结果为阳性。与非反应性检测相比,非反应性检测患者的感染后中位时间(p=0.01)、症状发作后中位时间(p=0.009)、Fiebig 分期 III 与 IV 的比例(p=0.003)、WB 结果阴性(p=0.007)、HIV-RNA 水平较高(p=0.001)和 CD4+和 CD8+细胞计数较低(p=0.03,p<0.001)。在检查 AHI 持续时间内的检测灵敏度时,HIV 传播后 5 周时 HIV 检测的概率为 75.5%。INSTI 在反应性检测的比例(62.5%)、非反应性检测的决定因素以及感染后 5 周时 HIV 检测的概率方面提供了类似的结果(85.0%)。
使用 STAT-VIEW 快速自我检测对血清样本进行检测时,超过一半的 AHI 患者的血清学检测结果为阳性。考虑到检测灵敏度随感染时间的增加而显著提高,个体不应仅依靠阴性结果来准确排除至少 5 周内潜在 HIV 暴露后的 HIV 感染。尽管强烈反对在 AHI 期间使用快速检测,但在感染后 5-12 周仍观察到一些检测 HIV 的作用。